White Chad Norman 4
4 · Sonoma Pharmaceuticals, Inc. · Filed Dec 30, 2022
Insider Transaction Report
Form 4
White Chad Norman
Chief Financial Officer
Transactions
- Award
Stock option (right to buy)
2022-12-29+9,753→ 14,753 totalExercise: $1.08Exp: 2032-12-29→ Common Stock (9,753 underlying)
Footnotes (2)
- [F1]The options vest one third each on 12/29/2023, 12/29/2024 and 12/29/2025, or upon change of control.
- [F2]The options were awarded and granted to Mr. White for services performed as part of the Company's annual grant of stock options.